Millington Financial Advisors »

Acasti Pharma shares owned by Millington Financial Advisors

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Millington Financial Advisors from 13F filings

Historical chart of Millington Financial Advisors investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Millington Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Millington Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $60k 20k 2.99
2025-06-30 $67k 20k 3.35

More positions owned by Millington Financial Advisors

Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Spdr Series Trust Portfolio S&p400 (SPMD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Defiance Quantum (QTUM)
Spdr Series Trust Portfolio S&p600 (SPSM)
Ishares Tr U.s. Med Dvc Etf (IHI)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Innovator Etfs Trust Us Equity Accele (XBAP)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Oracle Corporation (ORCL)
Quanta Services (PWR)

View all positions for Millington Financial Advisors

Top funds holding Acasti Pharma

Nantahala Capital Management
AIGH Capital Management
Vanguard Group
ADAR1 Capital Management
Stonepine Capital Management
Renaissance Technologies
Citadel Advisors
Millington Financial Advisors
SeaCrest Wealth Management
National Bank Of Canada /fi/
Morgan Stanley
Tower Research Capital
Royal Bank of Canada
Activest Wealth Management
SBI Securities

View all funds holding Acasti Pharma